
Bayer Cropscience announced that Bayer AG and Cinven have reached a definitive agreement to sell Bayer’s Environmental Science Professional business for a purchase price of $2.6 billion (€2.4 billion).
Bayer AG (Bayer) is one of the promoters of Bayer Cropscience. It held 8.43% of the company’s capital as of December 31, 2021.
Cinven is an international private equity firm focused on building world-class global companies. Its funds invest in six key sectors: business services, consumer, financial services, healthcare, industrials and TMT (technology, media and telecommunications).
“This divestment represents a very attractive purchase price and allows us to focus on our core agricultural business and the successful execution of our Crop Science division’s growth strategy,” said Board Member Rodrigo Santos. Board of Directors of Bayer AG and Chairman of Crop Science. Division.
Environmental Science Professional is a global leader providing environmental solutions to control pests, diseases and weeds in non-agricultural areas such as vector control, professional pest control, vegetation management, forestry, turf and ornamental plants. As of 2021, the company had approximately 800 employees supporting operations and sales in over 100 countries.
Bayer announced its decision to sell the business in February 2021.
The transaction is expected to close in the second half of this year, subject to the satisfaction of customary closing conditions. Its net proceeds are to be used to reduce Bayer’s net financial debt.
Bayer CropScience is a global company with core competencies in the fields of health and nutrition life sciences.
The company reported a standalone net profit of Rs 84.80 crore in the quarter ended December 2021, compared to a net loss of Rs 45.10 crore in the previous quarter ended December 2020. Sales increased by 7, 83% year-on-year to reach Rs 990.10 crore in the December 2021 quarter.
Shares of Bayer CropScience were currently trading up 1.31% at Rs 4,499.85 on BSE.
Powered by Capital Market – Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear reader,
Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues.
However, we have a request.
As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.
Support quality journalism and subscribe to Business Standard.
digital editor